CMS overpaid for infusion drugs by $334 million, OIG says

NEWS IN BRIEF — Posted March 4, 2013

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Medicare program has overpaid for durable medical equipment infusion drugs by as much as 122% since 2005 because Congress directs it to use an outdated pricing structure, federal auditors stated in a report.

The majority of the DME drugs paid for between 2005-11 by Medicare exceeded what the program would have paid under the program’s average sales price system, which pays market rate estimates plus 6% for drugs billed to Medicare’s outpatient side of the program. DME drugs are paid under an average wholesale price system, which generally means higher pay rates. Medicare and its beneficiaries would have saved $334 million if pay for infusion drugs were based on the average sales price, the Health and Human Services Office of Inspector General stated in a February report.

Most years, the entitlement program spent more on milrinone lactate than on any other infusion drug — accounting for 24% to 62% of the yearly spending total for the category.

However, the analysis also found instances in which physicians were being underpaid for administering some drugs. For instance, the average sales price for the antiviral drug ganciclovir sodium was $65.03 in 2011, but the Medicare payment was $35.25, the same price it paid in 2005.

The OIG recommended that the Centers for Medicare & Medicaid Services seek a legislative change to authorize paying for DME infusion drugs using the average sales price methodology. Such a change could have saved the program $72 million in 2011.

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn